Status:
COMPLETED
Effect of Myoma Removal on Blood Pressure and Erythropoetin Level
Lead Sponsor:
Shiraz University of Medical Sciences
Conditions:
Myoma
Hypertension
Eligibility:
FEMALE
22-55 years
Phase:
NA
Brief Summary
The effect of myoma removal was studied on 28 patients with hypertension and myoma by holter monitoring and erythropoetin level check.
Detailed Description
Background: Myoma is the most common gynecoid tumor and produces many vasoactive substances, which may be a cause for secondary hypertension. Early reports suggested the association of myoma and hype...
Eligibility Criteria
Inclusion
- candidate for myoma removal by hysterectomy
- operable
- hysterectomy is indicated
Exclusion
- patient refusal
- inoperable patients
- other secondary cases of hypertension
Key Trial Info
Start Date :
May 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2009
Estimated Enrollment :
28 Patients enrolled
Trial Details
Trial ID
NCT00898170
Start Date
May 1 2008
End Date
March 1 2009
Last Update
May 12 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cardiology Ward Shiraz University of Medical Sciences
Shiraz, Fars, Iran, 51318